share_log
Reuters ·  Mar 27 11:00
BioXcel Therapeutics Q4 Operating Income USD -10.493 Million Vs. IBES Estimate USD -16.2 Million
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 381

Recommended

Write a comment